论文部分内容阅读
48例T2DM在合理饮食、适当运动、定期测量血糖等措施的基础上,给予孚来迪每次0.5~1mg,每日3次,餐前口服,二甲双胍0.25每日3次,餐后口服,共观察8周。结果:空服血糖(FPG)治疗前10.5±2.1mmol/L,治疗后6.03±1.1mmol/L,P<0.01,餐后2小时血糖(PPG)治疗前14.71±3.4mmol/L,治疗后8.3±1.7mmol/L,P<0.01。理想及一般控制率81.25%,低血糖发生2例,占4.17%。结论:孚来迪与二甲双胍联合治疗T2DM副作用少,患者耐受性好。
On the basis of reasonable diet, proper exercise and regular measurement of blood sugar, 48 cases of T2DM were given Fuduidi 0.5-1mg, 3 times daily, pre-meal oral, metformin 0.25 three times a day, after meals, a total of Observed for 8 weeks. Results: The levels of plasma FPG before treatment were 10.5 ± 2.1mmol / L, 6.03 ± 1.1mmol / L after treatment, P <0.01, 14.71 ± 3.4mmol / L before 2 hours postprandial blood glucose (PPG) ± 1.7mmol / L, P <0.01. The ideal and general control rate of 81.25%, 2 cases of hypoglycemia, accounting for 4.17%. Conclusions: Combination of furadidi and metformin has less side effects in patients with T2DM and patients are well tolerated.